Press-release for stocks for novavax, inc.

Prices are updated after-hours

Novavax's Updated COVID-19 Vaccine Now Approved in the EU
Published: 2023-10-31 (Crawled : 21:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M

| -41.59% | O: 0.6% H: 5.22% C: 4.48%
covid-19 vaccine approved

Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published: 2023-10-18 (Crawled : 13:30) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M

| -39.69% | O: -0.78% H: 2.5% C: 1.09%
covid-19 vaccine prototype approval

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
Published: 2023-01-18 (Crawled : 14:20) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M

| -68.73% | O: 1.53% H: 8.47% C: -1.19%
covid-19 vaccine approved nuvaxovid

Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Adolescents
Published: 2022-12-07 (Crawled : 16:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M

| -76.82% | O: 0.0% H: 6.02% C: 2.62%
covid-19 vaccine canada approved nuvaxovid

| -90.12% | O: 0.97% H: 0.0% C: -6.47%
covid-19 vaccine granted approval

| -90.93% | O: -1.82% H: 1.31% C: -6.48%
covid-19 vaccine granted approval

Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
Published: 2022-08-12 (Crawled : 14:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M

| -90.36% | O: 2.03% H: 4.62% C: 0.75%
covid-19 vaccine approved

Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan
Published: 2022-07-26 (Crawled : 12:20) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M

| -92.99% | O: -0.2% H: 6.0% C: 2.08%
covid-19 japan vaccine approval

Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published: 2022-04-19 (Crawled : 12:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M

| -93.39% | O: -9.57% H: 4.12% C: 2.61%
covid-19 japan vaccine approval

New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Published: 2022-02-03 (Crawled : 23:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M

| -95.6% | O: -0.2% H: 3.78% C: 1.16%
covid-19 approval covid vaccine grant granted

South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
Published: 2022-01-12 (Crawled : 12:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M

| -97.1% | O: -2.2% H: 3.46% C: -0.75%
drug vaccine covid food

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | $13.15 -0.61% 0.0% 1.6M

| -2.88% | O: 1.18% H: 0.0% C: 0.0%
NVAX | $3.895 -2.38% -2.44% 3.7M

| -97.71% | O: 5.55% H: 0.0% C: 0.0%
covid-19 new drug application drug approval covid vaccine submission

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M

| -97.71% | O: 1.31% H: 0.0% C: 0.0%
application license approval submission nvx-cov2373

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
Published: 2021-11-03 (Crawled : 14:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M

| -97.86% | O: 9.04% H: 1.68% C: -1.49%
covid vaccine approval covid-19

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
Published: 2021-10-29 (Crawled : 12:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M